Difference between revisions of "Mianserine-sertraline"

From Psychiatrienet
Jump to: navigation, search
(Created page with '{{Drugswitch | from = mianserine | to = sertraline | stop = * '''Day 0:''' gradually reduce dosage of mianserine to a maximum of 60 mg/ day. * '''Day 1:''' reduce a dosage of ...')
 
Line 7: Line 7:
 
| start =   
 
| start =   
 
* '''Day 1:''' simultaneously start sertraline in a normal dosage of 50 mg/day.
 
* '''Day 1:''' simultaneously start sertraline in a normal dosage of 50 mg/day.
* '''Day 8:''' stop administration of mianserine and only continue administration of sertraline only.
+
* '''Day 8:''' stop administration of mianserine and only continue administration of sertraline.
 
* If necessary, increase the dosage of sertraline.
 
* If necessary, increase the dosage of sertraline.
 
| info =  
 
| info =  
 
* Caution with this switch is necessary, because sertraline dose-dependently slows the metabolism of mianserine via CYP2D6. }}
 
* Caution with this switch is necessary, because sertraline dose-dependently slows the metabolism of mianserine via CYP2D6. }}

Revision as of 12:58, 6 May 2009

Mianserine
Type Antidepressant
Group other
links
PubChem 4184
PubMed Mianserine
Kompas (Dutch) Mianserine
Wikipedia Mianserine
Sertraline
Type Antidepressant
Group SSRI
links
Medscape Sertraline
PubChem 68617
PubMed Sertraline
Kompas (Dutch) Sertraline
Wikipedia Sertraline

Switch medication from mianserine to sertraline.[1] [2]

Nietinrijdenbord.png Stop mianserine
  • Day 0: gradually reduce dosage of mianserine to a maximum of 60 mg/ day.
  • Day 1: reduce a dosage of 60 mg/day to 30 mg/day.
Eenrichtingbord.png Start sertraline
  • Day 1: simultaneously start sertraline in a normal dosage of 50 mg/day.
  • Day 8: stop administration of mianserine and only continue administration of sertraline.
  • If necessary, increase the dosage of sertraline.
Infobord.png More information
  • Caution with this switch is necessary, because sertraline dose-dependently slows the metabolism of mianserine via CYP2D6.
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.